Renal protection in diabetes: Role of glycemic control

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Fioretto, Paola ^a,b   Bruseghin, Marino ^a   Berto, Ilaria ^a   Gallina, Pietro ^a   Manzato, Enzo ^a   Mussap, Michele ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; REMISSION; RENAL PROTECTION;

EID: 33645472464     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121343     Document Type: Conference Paper

References (33)

1. US Renal Data System: Annual Data Report 2005. Available: http://www.usrds.org/adr.htm. Accessed February 23, 2006
2. Parving H-H, Mauer M, Ritz E: Diabetic nephropathy. In: Brenner and Rector's the Kidney, 7th Ed., edited by Brenner BM, Philadelphia, WB Saunders, 2004, pp 1777-1818
3. Pirart J: Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Metab 3: 173-182, 1977
4. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78: 785-794, 1985
5. The EURODIAB IDDM Complications Study Group: Microvascular and acute complications in insulin dependent diabetes mellitus: The EURODIAB IDDM Complications Study. Diabetologia 37: 278-285, 1994
6. Steffes MW, Sutherland DER, Goetz FC, Rich SS, Mauer SM: Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus. N Engl J Med 312: 1282-1287, 1985
7. Mauer SM, Goetz FC, McHugh LE, Sutherland DE, Barbosa J, Najarian JS, Steffes MW: Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes 38: 516-523, 1989
8. Mauer SM, Steffes MW, Connett J, Najarian JS, Sutherland DE, Barbosa J: The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys into diabetic patients. Diabetes 32: 948-952, 1983
9. Barbosa J, Steffes MW, Sutherland DER, Connett JE, Rao KV, Mauer SM: The effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA 272: 600-606, 1994
10. Diabetes Complications and Control Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
11. UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853, 1998
12. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
13. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159-2167, 2003
14. Ohkubo Y, Kishikawa H, Araki E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin dependent diabetes: A randomized prospective 6-year study. Diab Res Clin Pract 28: 103-117, 1995
15. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332: 1251-1255, 1995
16. The Diabetes Control and Complications Study Group: The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-1298, 1996
17. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321: 405-412, 2000
18. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH: Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold. Kidney Int 60: 219-227, 2001
19. Bohman S-O, Tyden G, Wilczek H, Lundgren G, Jaremko G, Gunnarsson R, Ostman J, Groth G: Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306-308, 1985
20. Wilczek HE, Jaremko G, Tyden G, Groth CG: Pancreatic graft protects a simultaneously transplanted kidney from developing diabetic nephropathy: Al to 6 year follow-up study. Transplant Proc 1: 1314-1315, 1993
21. Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW: The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 32: 80-85, 1989
22. Rossing P, Hougaard P, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: A 10-year prospective observational study. Diabetes Care 25: 859-864, 2002
23. Bojestig M, Arnqvist HJ, Karlberg BE, Ludgvisson J: Glycemic control and prognosis in type 1 diabetic patients with microalbuminuria. Diabetes Care 19: 313-317, 1996
24. Felt-Rasmussen B, Mathiesen ER, Deckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1: 1300-1304, 1986
25. The Diabetes Control and Complications Trial Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720, 1995
26. Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23[Suppl 2]: B21-B29, 2000
27. Bangstad HJ, Osterby R, Dahl-Jorgensen K, Berg KJ, Hartmann A, Hanssen KF: Improvement of blood glucose control in IDDM patients retards progression of morphologic changes in early diabetic nephropathy. Diabetologia 37: 483-490, 1994
28. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic nephropathy. Kidney Int 59: 702-709, 2001
29. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596-1605, 2004
30. Fioretto P, Mauer SM, Bilous RW, Goetz FC, Sutherland DER, Steffes MW: Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 342: 1193-1196, 1993
31. Roys S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with a memory. Proc Natl Acad Sci USA 87: 404-408, 1990
32. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1322, 1988
33. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 27[Suppl]: S79-S83, 2004